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Abstract 
Nicotinic acetylcholine receptors (nAChRs) modulate synaptic activity in the central nervous 
system. The α7 subtype, in particular, has attracted considerable interest in drug discovery as 
a target for several conditions, including Alzheimer’s disease and schizophrenia. Identifying 
agonist-induced structural changes underlying nAChR activation is fundamentally important 
for understanding biological function and rational drug design. Here, extensive equilibrium 
and nonequilibrium molecular dynamics simulations, enabled by cloud-based high-
performance computing, reveal the molecular mechanism by which structural changes 
induced by agonist unbinding are transmitted within the human α7 nAChR. The simulations 
reveal the sequence of coupled structural changes involved in driving conformational change 
responsible for biological function. Comparison with simulations of the α4β2 nAChR subtype 
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identifies features of the dynamical architecture common to both receptors, suggesting a 




Nicotinic acetylcholine receptors (nAChR) are prototypical members of the Cys loop 
pentameric ligand-gated ion channel (pLGICs) family, which also includes the GABAA and 
5-HT3 receptors.1-3 In the peripheral nervous system, nAChRs mediate fast excitatory 
synaptic signalling whereas in the brain they mostly modulate the synaptic signalling of a 
wide range of neurotransmitters.4 Neuronal nAChRs expressed in the CNS are putative 
targets for the treatment of a variety of neurodegenerative diseases, neurodevelopmental 
disorders, pain and addiction5, and analogous nAChRs in the insect CNS are targets for 
neonicotinoid pesticides.6 The α7 subtype is one of most abundant nAChRs subtypes in the 
mammalian CNS5, attracting considerable interest for drug discovery due to its role in 
cognition, attention, memory and sensory processing.7 α7 nAChR dysfunction is implicated 
in disorders such as Alzheimer’s and Parkinson's diseases and schizophrenia.5 
There are many nAChR subtypes, distinguished by their specific combination of five 
subunits1-3, 8. Despite differences in sequence (Figure S1), all subunits share the same basic 
architecture (Figure 1), consisting of a N-terminal extracellular domain (ECD), a 
transmembrane domain (TMD), a variable cytoplasmic domain (ICD) and a short 
extracellular C-terminal domain.1-3 The structures of nAChRs (and other pLGICs) have been 
revealed by cryo-electron microscopy9-11 and X-ray crystallography12. The agonist-binding 
pockets are located in the ECDs at the interface between two neighbouring subunits (Figure 
1). The α7 receptor subtype is unusual in being formed of five identical α7 subunits 
symmetrically arranged around a central ion channel1-3 and thus presents five equivalent 




Figure 1. Close-up view of the ligand-binding pocket of human α7 nAChR. A model for the α7 subtype was 
built using as a template the α4 subunit of the human α4β2 nAChR12. Nicotine was modelled in two 
nonconsecutive binding pockets, similar to what is observed in the human α4β2 nAChR structure12 (see 




Binding of acetylcholine (and other agonists such as nicotine) leads to opening of the ion 
channel, causing a flow of positive ions across the membrane, triggering depolarisation and 
signalling mechanisms.2,14 Several regions at ECD-TMD interface have been shown to be 
essential for linking the agonist binding site to the channel gate (e.g.15-25), namely the 10-
M1 region (which covalently links the ECD and TMD) and the Cys, F and 1-2 loops, 
which are in direct contact with the M2-M3 linker, a well-established gating control 
element.20,22,26-30 However, while the application of a variety of experimental approaches has 
led to a greater insight into the function of nAChR, the conformational changes induced by 
agonist binding/unbinding and how those are communicated to the ion channel remain poorly 
defined.  Answering this question requires knowledge of the dynamics of the protein and the 
temporal evolution of the conformational changes that take place upon ligand (un)binding. 
Biomolecular simulations have the potential to investigate these questions31, but face serious 
challenges associated with the large size of the systems and timescales involved; we show 
here that these can be overcome by the use of cloud-based high-performance computing 
(HPC) and by advanced, nonequilibrium molecular dynamics (MD) simulations, 
complementing standard equilibrium MD. In previous work on human α4β2 nAChR32, we 
demonstrated how a combination of equilibrium and nonequilibrium MD simulations 
identified the structural motifs involved in signal propagation upon nicotine unbinding and 
the sequence of the events associated with the first steps of this process. Here, we have 
applied this novel approach to the human α7 nAChR, using cloud-based nonequilibrium 
simulations to complement more traditional high-performance computing to achieve long 
timescales and extensive sampling. We identify the dynamic structural mechanism of 
receptor response to nicotine and, by comparison with the human α4β2 nAChR, we find a 
common signal propagation pathway in nAChRs, which may generally apply to pLGICs.  
Extensive equilibrium MD simulations (totalling 10 μs), with and without nicotine bound, 
were performed to identify the conformational changes induced by the ligand in the human 
α7 nAChR receptor. These simulations show that nicotine induces conformational changes in 
the binding pocket region, namely in loop B and C and also at the ECD:TMD interface, 
namely in the Cys and F loops and in the M2-M3 linker (Figures S10-S13). These results 
correlate well with the experimental evidence indicating that loop B, C and F have a role in 
binding (e.g.33,34) and agonist affinity35,36. Structural changes are also observed in the second 
layer of residues surrounding the binding site, mainly in the extracellular selectivity filter 
region (Figure S14). Note that a despite some differences in amplitude, similar structural 
changes are observed between the two binding pockets (Figure S10-S11). Although loop F 
has been shown to be essential for binding13, its role in signal propagation remains 
elusive.37,38 In our nicotine-bound equilibrium simulations, the motions of the upper part of 
loop F (residues D186-Y190) are coupled to the movements of the ECDs (right-side panels in 
Figure S15-S16), mostly to the binding-site region (loops B, C and loop D). The dynamics of 
the lower part of loop F (residues P192-W196) are highly correlated with the ECDs (namely 
the loops A, B, C and D in the binding pockets and the Cys loop at the interface between 
domains) and the TMDs (namely transmembrane helices M1, M2 and M3 and the M2-M3 
linker).  
When nicotine is present in the binding pockets, the dynamics of the M2-M3 linker is highly 
correlated not only with transmembrane helices 1, 2 and 3 but also with the Cys loop and 
some of the structural motifs forming the binding pockets, namely loops A, B and C (Figure 
S17). Several experimental studies have shown that mutations in the M2-M3 linker alter 
channel gating and disrupt the communication between domains in nAChRs (e.g.20,22,26,28-
30,39,40) and in other pLGICs (e.g.27,41-45).  
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These simulations of human α7 nAChR, combined with results for the human α4β2 nAChR32, 
reveal a common pattern of nicotine-induced structural rearrangements. Despite the 
differences in sequences between the two receptors, including differences in the Cys, B and C 
loops and M2-M3 linker (Figures S1-S2), similar conformational changes are observed in 
these structural elements. The largest difference in behaviour between the subtypes occurs in 
loop A, which shows a significant rearrangement in α7 but not in the α4β2 subtype.  
Here, a set of 450 nonequilibrium simulations without nicotine was performed to identify the 
signal propagation pathway in the α7 nAChR. The equilibrium and nonequilibrium 
simulations are complementary approaches. The former allows for identification of the 
agonist-induced conformational changes (after hundreds of nanoseconds), while the latter 
allows for the determination of the order of the events associated with signal propagation and 
interdomain communication.  
In all nonequilibrium simulations performed, both nicotine molecules were instantaneously 
annihilated. These simulations reveal the response of the system to this perturbation, 
specifically showing the mechanical and dynamical coupling between structural elements 
involved in the response (Figures 2, S20-S22 and Movie 1). Note that the nonequilibrium 
simulations performed here do not imply free energy calculations (e.g.46-49). In this case, it is 
the introduction of a perturbation that forces the system out of equilibrium. The Kubo-
Onsager approach pioneered by Ciccotti50-52 was used to compute the response of the receptor 
to nicotine removal (Figures S18-S19), by comparing the differences in the evolution of the 
simulations with and without nicotine, averaged over large numbers of simulations. The 
subtraction approach, and averaging over multiple (450) short simulations, allows 
conformational changes and their temporal sequence to be identified and their statistical 
significance to be determined. These nonequilibrium simulations are not intended to model 
the physical process of ligand (un)binding, nor the transition between states and, due to the 
artificial nature of the perturbation, the timescales observed for the response of the receptor 
do not represent the biological timescales.32 It is also important to note that, due to the short 
timescale of the nonequilibrium simulations (5 ns), the observed deviations reflect only the 





Figure 2- Signal propagation pathway from the ECD to the TMD in the α7 nAChR. Average Cα-positional 
deviation at times 0, 0.05, 0.5, 1, 3 and 5 ns following nicotine annihilation from the first binding pocket. The 
Cα deviations between the simulations with and without nicotine were determined for each residue, and the final 
values were averaged over the 450 pairs of simulations (Figure S18-S19). The Cα average deviations are 
mapped onto the average structure for the system without nicotine using the colour scheme in the scale on the 
right.  
 
The 450 nonequilibrium simulations were performed in five days using the Oracle Cloud and 
100 compute instances managed via cluster-in-the-cloud (https://cluster-in-the-
cloud.readthedocs.io and https://doi.org/10.5281/zenodo.3246253). Profiling cloud versus on-
premises computing suggested that these simulations would have taken around three months 
on shared local HPC resources. This demonstrates the rapid turnaround and throughput of 
high-end scientific computation (in this case intensive, physics-based atomistic MD 
simulations) that is now possible using such cloud services. The approach here combines 
strengths of traditional HPC (for equilibrium simulations) with the cloud (for nonequilibirum 
simulations).  
The nonequilibrium simulations show that signal transmission in the α7 receptor starts in the 
binding pocket region, in loop C, and it then propagates to loop F and finally to the TMDs 
(Figure 2). Unsurprisingly, loop C (residues S206-Y217) is the first region to respond to 
ligand removal, and after 0.05 ns, some conformational rearrangements are already observed 
in this region. Over the next few nanoseconds, gradual and cumulative conformational 
changes propagate to the top (residues D186-Y190) and then to the lower part of loop F 
(residues P192-W196) and afterwards to the TMDs via the M2-M3 linker (residues T286-
V290) (Figures 2, S20-S21 and Movie 1). Note that the two binding pockets show similar 
responses to nicotine annihilation, with the same order of events observed for each (Figures 
S18-S19). All the structural motifs identified here have been shown experimentally to be 
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involved in ligand binding and signal transduction: Loop C is important for binding (e.g.33,34), 
contributing to binding the ammonium group of the agonists13,53; Loop F plays a role in 
ligand binding affinity, and specificity13; and the M2-M3 linker is essential for channel gating 
and communication between domains (e.g.22,26-30,39-45), and insertions/deletions of residues in 
this region directly affect the open-channel lifetime.30  
 
 
Figure 3- The ECD:TMD signal propagation pathway in human α7 and α4β2 nAChRs. The 
deviations for the α4β2 nAChR are taken from32. Note that although the apparent rate of propagation 
is different, the sequence of conformational changes associated with the initial steps of signal 
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propagation is the same for both subtypes, i.e. the structural elements involved (loops C, F and M2-
M3 linker), and the sequence of structural changes, are the same.  
 
The signal propagation pathway observed here for the α7 nAChR is remarkably similar to 
that of the α4β2 nAChR.32 The structural motifs involved in the signal transmission and the 
sequence of changes are the same between the two subtypes (Figure 3 and Movie 2). This 
supports the idea that, despite differences in sequence13,54, all family members share a 
common communication mechanism. Our simulations show differences in the rate of 
propagation, which may relate to differences in function and response between receptor 
subtypes. All known pLGICs have a similar molecular architecture1-3 and it has been shown 
experimentally that all of the structural elements identified here (loops C, F, Cys and the M2-
M3 linker) are important not only in nAChR (e.g.15,20,22,26,28,30,39,40) but also in other 
homologous receptors (e.g.37,38,55-58). Furthermore, it is also known that chimeric pLGICs 
formed by modular combinations of different ECDs and TMDs are still functional.21,59,60  
Our findings identify a general mechanism for communication within this receptor family: 
the structural rearrangements associated with signal propagation start in loop C and are 
subsequently transmitted, gradually and cumulatively, to loop F, and then to the TMDs via 
the M2-M3 linker. This mechanism is consistent with experimental data and provides a 
molecular-level rationalisation of those data. This dynamic mechanism of signal propagation 
not only confirms the involvement of specific structural motifs but also shows, for the first 
time, the complex contribution of Loop F to signal propagation. It should also assist in the 
design of agonists or allosteric modulators to target nAChRs and other biomedically relevant 
pLGICs. The approach used here, combining extensive equilibrium and nonequilibrium 
simulations, is a valuable tool to study conformational changes in allosteric proteins.  
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A homology model for the extracellular and transmembrane domains of the human α7 
nicotinic receptor was constructed using the α4 subunit from the crystal structure of the 
human α4β2 nicotinic receptor (PDB code: 5KXI)1 as a template. This X-ray structure is 
thought to reflect a desensitised state of the receptor with two agonists molecules present in 
the binding pockets and a closed, non-conducting ion channel1.  
The sequence for the human α7 subunit was obtained from the UniProt database2 (code 
P36544) and aligned with the template using Clustal Omega3, 4. The sequence identity 
between the α7 and the α4 subunits is 48%, and it was determined using BLAST5. It 
should be noted that in this work, the intracellular region of the receptor (residues 345-
354) was not modelled due to the lack of structural information. Twenty different 
models were generated with the MODELLER 9v176, and the one with the lowest value 
for MODELLER's objective function was selected and further validated using 
PROCHECK7. Nicotine was modelled in two of the five binding pockets with binding 
modes similar to nicotine in the structure of the α4β2 receptor1. It has been shown 
experimentally that the binding of agonists to two nonconsecutive binding pockets 
enables proper activation of homomeric Cys-loop receptors.8 Unless stated otherwise, 








Figure S1. Sequence alignments for several nAChR subunits. All sequences were taken from the UniProt 
database.2, namely codes Q15822, P32297, P43681, P30532, Q15825, P36544, Q9UGM1, Q9GZZ6, 
P17787, P30926, Q07001 and Q04844 for the α2, α3, α4, α5, α6, α7, α9, α10, β2, β4, δ and ε subunits, 
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respectively. The loops forming the binding pockets and other structural elements are labelled 
accordingly. The intracellular regions are highlighted in grey. The aromatic residue in loop B known to 
directly interact with the ammonium group of the agonist9 is coloured in dark red. Please zoom into the 
image for detailed visualisation of the sequence alignments.  
 
 
Figure S2. Differences in the binding pocket between the human α7 and the α4β2 subtypes. For 
clarity, the residues numbering in the α7 subtype refers to the sequence (UniProt2 code P36544) whereas 
in the α4β2 subtype it relates to the 5KXI X-ray structure.1 The residues that are different between the 
two subtypes are shown with green (principal subunit) and cyan (complementary subunit) sticks. Nicotine 
is represented in balls-and-sticks. Note that the structure representing the α7 subtype (left side image) is 
the homology model constructed using crystal structure of the α4β2 subtype1 as template. The structure 
for the α4β2 subtype (right side image) corresponds to the crystal structure (PDB code: 5KXI).1  
 
Protonation state of protonatable residues 
The protonation state of each titrable site at pH 7.0 was determined using a combination 
of Poisson-Boltzmann calculations and Metropolis Monte Carlo simulations similarly 
to10. The Poisson-Boltzmann calculations were performed using MEAD (version 
2.2.9)11-13, and the Metropolis Monte Carlo simulations were done with PETIT (version 
1.6).14 All the settings were similar to the ones described in10. Based on these 
calculations, all lysines, arginines, aspartates, and glutamates were considered charged. 
Histidines were found to be in different protonation states:  H85, H127, H137, H318 
and H320 were considered neutral whereas H163 and H319 were (positively) charged. 
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The nicotine molecules were treated as positively charged because the pKa value for its 
pyrrolidine N site is ~8.15 The overall charge for the receptor-nicotine complex was -23.   
 
Equilibrium simulations 
The receptor was inserted in a pre-equilibrated POPC bilayer using LAMBADA and 
InflateGRO216, resulting in a membrane-protein system containing 420 lipids. Two 
systems were prepared, one with no agonist bound to the receptor (hereafter named 
APO) and a second one, with nicotine bound in two of the five binding pockets 
(hereafter called NCT). All systems were solvated using TIP3P water molecules17, and 
an ionic concentration of 0.1 M sodium chloride was used.  
All equilibrium MD simulations were performed using GROMACS (version 5.1.4)18 on 
the University of Bristol’s High-Performance Computer, BlueCrystal (Phase 4). The 
Amber ff99SB-ILDN19 force-field was used to describe the protein, whereas the S-
lipids forcefield was used for the membrane.20, 21 The parameters for the protonated 
nicotine were taken from our previously published work10, 22, in which (as here) the R 
configuration was chosen for the nitrogen stereocenter, as observed in the human α4β2 
crystal structure.1 All simulations were performed at a constant temperature of 310 K, 
and the velocity-rescaling thermostat23 was used, with separate couplings for the solutes 
and solvent, using a relaxation time constant of 0.1 ps. A Berendsen barostat24 was used 
to keep the pressure at 1 bar, with a coupling constant of 1.0 ps and isothermal 
compressibility of 4.5×10−5 bar−1. The pressure was coupled semi-isotropically, 
resulting in the independent coupling of the lateral P(x+y) and perpendicular (Pz) 
pressures. A time step of 2 fs was used for integrating the equations of motion. Non-
bonded long-range electrostatic interactions were calculated using PME25 beyond a 12 
Å cutoff. The same 12 Å cutoff was used for the van der Waals interactions with long-
range dispersion corrections for the energy and pressure.26 The neighbours list was 
updated every 20 steps. All bonds were constrained to their equilibrium lengths with the 
LINCS algorithm27 except for the water molecules, which were kept rigid with the 
SETTLE algorithm.28  
The solvated protein-membrane systems were energy minimised, equilibrated (for 20 
ns) and simulated according to the protocol described previously in10. Ten unrestrained 
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MD simulations, each 500 ns long, were performed for each system, totalling 10 μs of 
simulation.  
 
Figure S3. View of the nicotine-bound α7 system. The protein is rendered as a cartoon, whereas the 
POPC lipids are represented as magenta sticks. Nicotine (yellow), Na+ (orange) and Cl– (green) ions are 
shown with spheres. 
 
It should be noted, that similarly to the X-ray structure1 used as a template for our model, 
our α7 receptor model is thought to represent a desensitised state in which the ion channel 
adopts a closed V-shaped conformation despite the agonists bound in the binding pockets. 
According to the MWC allosteric model, a minimum of four conformational states (Figure 
S4) are needed to represent the working cycle of pentameric ligand-gated ion channels 
(pLGICs)29: three primary states (namely Resting, Active, and Desensitised) and an 
intermediate state (which may include multiple intermediate conformations). According 
to this model, the binding of agonists to the binding pockets induces the transition from 
a closed resting to an open, active conformation. Prolonged binding of the agonist leads 
to a high affinity, agonist-bound, nonconducting desensitised state.29 The exit of the 
agonist from the binding pockets returns the receptor to the resting state again.29 The 
equilibrium simulations reported here focus on Desensitised (ligand bound, NCT) state, 
while the APO simulations give an indication of the Desensitised to Resting transition 
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(red arrow in Figure S4). We do not aim to model channel opening, and these 
simulations do not do so. 
 
Figure S4. Simplified conformational state scheme representation for the working cycle of pLGICs. 
R, A, D and I refer to resting, active, desensitised and intermediate states, respectively (see text for more 
details). The red arrow corresponds to the state transition sampled during our equilibrium simulations, 
which begin in what is thought to be the desensitized state.  
 
Nonequilibrium simulations 
To study signal propagation between the binding pockets and the TMDs, a large set 
(450) of very short (5 ns) nonequilibrium simulations was performed. These simulations 
drive, and allow for the characterisation of rapid conformational changes in the system 
by using the Kubo-Onsager approach30-32. It should be noted that the subtraction 
technique30-32 is just a particular instance of the Kubo-Onsager approach that can be 
used when the two sets of simulations (with and without a perturbation) are correlated30, 
and it allows for the cancellation of the noise arising from the intrinsic fluctuations of 
the system and for the identification of the response to the perturbation in a statistically 
significant way. Note that in the long equilibrium simulations, due to the limited 
sampling (10 replicates/system) and the lack of a driving force, it is not possible to 
determine the order of the events associated with any propagation of conformational 
changes from the binding pockets to the TMDs. 
The starting conformations for the short nonequilibrium simulations were extracted 
from the equilibrated part of the 500 ns equilibrium NCT simulations (from 50-500 ns). 
Conformations were taken every 10 ns (45 frames per replicate), and in each, the 
nicotine molecules were removed from the binding pockets (Figure S5), i.e. simply 
annihilated. Note that in order to maintain the electroneutrality of the system required 
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for PME, two negative ions were also removed from the solvent. The effect of nicotine 
annihilation was studied by the Kubo-Onsager method.30-32 According to this method30-
32, the response (over the first few nanoseconds) of a system to a perturbation can be 
directly measured by averaging a given property (in this case, the position of the Cα 
atoms) in perturbed (APO) and unperturbed simulations (NCT) at a given time, as long 
as enough data is gathered (Figure S5A). For each pair of unperturbed equilibrium NCT 
and perturbed nonequilibrium APO simulations, the difference in position for each Cα 
atoms was determined at equivalent points in time, namely after 0, 50, 500, 1000, 3000 
and 5000 ps of simulation (see Figure S5B). The use of the Cα atoms is this analysis is a 
straightforward way to identify the most pronounced conformational rearrangements 
while reducing the noise coming from the fluctuations of the side-chains. Note that as 
we are only calculating the difference in position between 2 conformations, no special 
code is needed and, any tool able to calculate the distance between two atoms (e.g. rms 
or distance tools in GROMACS18) can, in principle, be used for this analysis. The 
positional deviations values obtained at each point in time were then average over all 
450 simulations. Since the data is collected from a large number of simulations (450), 
we can be sure of the statistical significance of the structural changes identified due to 




Figure S5. Scheme for the nonequilibrium simulations. A. From the model of the human α7 nicotinic 
receptor structure with nicotine bound, 10 equilibrium MD simulations, 500 ns each, were performed 
(blue). These simulations (NCT bound, shonw in blue) were used to generate starting structures for the 
short APO nonequilibrium simulations (red): conformations were sampled every 10 ns, beginning from 
the 50 ns structures of the NCT simulations, giving a total of 450 short APO simulations. B. For each pair 
of unperturbed NCT and perturbed APO simulations, the positional deviations of each Cα at equivalent 
times (namely 0, 50, 500, 1000, 3000 and 5000 ps) were determined.  
 
 It is important to note that the removal of the ligands from the binding pockets is not 
intended to represent the physical process of unbinding. Its primary purpose is to create 
a perturbation in the system and force a response from the receptor. Furthermore, it also 
should be noted that these nonequilibrium simulations (due to their short timescales and 
the artificial nature of the perturbation) are not attempting to explain the entire 
mechanism of gating or how ligand binding and unbinding induce channel opening and 
closing. Instead, they allow the identification of the first conformational changes 
associated with signal propagation. Nonetheless, the structural elements of the 
communication pathway revealed by the nonequilibrium simulations are likely to be 
involved in the response to binding and unbinding of agonists and in the conformational 
rearrangements occurring in the transitions between states. The simulation conditions 
for the nonequilibrium simulations were identical to those described above for the 
equilibrium ones. 
Having used the University of Bristol HPC ‘BlueCrystal’ for the equilibrium 
simulations, in this part of the work (nonequilibrium MD), we made use of public cloud 
computing rather than our institution’s HPC. Specifically, we made use of the Oracle 
Cloud Infrastructure (https://cloud.oracle.com/en_US/iaas) and the bare-metal instances 
it provides. The basic design mirrors an on-premises HPC cluster: there is a head node 
(in this case a virtual machine of "shape" VM.Standard2.2) and a number of compute 
nodes (one hundred instances of the bare-metal node BM.Standard2.52). All the nodes 
have access to a shared filesystem using the NFS protocol. The expected I/O 
requirements for one hundred simultaneous GROMACS jobs didn’t require a more 
sophisticated shared filesystem or an alternative like an object store. The compute nodes 
are dual-socket servers with two "Intel Xeon Platinum 8167M CPU @ 2.00GHz" CPUs 
giving 52 cores and 104 hyperthreads per node and 768 GiB of RAM with a two 10 
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Gb/s Ethernet network interfaces. These are the Oracle Server X7-2 model 
(www.oracle.com/us/products/servers/arch-wp-oracle-servers-x7-2-x7-2l-3852567.pdf) 
servers. The resources were located in the us-ashburn-1 region in two availability 
domains. To configure the cluster, two tools were used with a separation of concerns, 
each managing a diff erent layer of the software stack. Terraform 
(https://www.terraform.io) was used to manage the deployment and configuration of the 
cloud resources: the instances, the virtual cloud networks and storage up to the point of 
installing the operating system. Ansible (https://www.ansible.com) was used to manage 
the configuration of the operating systems, installing the job scheduler and cluster 
configuration and installing the application. With this approach, simply changing the 
Terraform ‘provider’ would enable the same system to be built in another public or 
private cloud. All of this was managed via cluster-in-the-cloud 
(https://doi.org/10.5281/zenodo.3246253). The operating system for all nodes was 
Oracle-Linux-7.502018.06.14-0 based on RedHat Enterprise Linux 7.x. The job 
scheduler used for the cluster was SLURM version 17.11.7. GROMACS itself was built 
from source (www.gromacs.org) in to an operating system native package (RPM) 
format using the .SPEC file in the Ansible repository. All simulations were completed 
over a real-time period of 5 days. Benchmarking against BlueCrystal Phase 4 indicated 
that the simulations would have taken ~90 days to run locally. The speed-up was a 
combination of GROMACS running faster on the cloud HPC compute nodes, and the 
elastic scaling nature of the cloud providing more on-demand compute capacity versus 
what was available locally on a shared multi-user cluster. Each individual GROMACS 
simulation took ~8 hours to complete on a cloud 2x28 core Platinum Xeon 8167M node 
versus ~17 hours on a BlueCrystal Phase 4 2x14 core Gold Xeon E5-2680v4 node. 
BlueCrystal Phase 4 is a shared cluster with many users, and we estimated that only 10 
nodes would be available on average on this shared resource via the queue. This is 
compared to 100 nodes that were available elastically on the cloud. 
 
Analysis 
All the analyses were performed using GROMACS18 tools and in-house tools. All 
molecular images were created with PyMOL.33, 34 PCA analysis was used to examine 
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the sampling and equilibration of the replicates (similarly to, e.g.35-37) and to identify the 
most relevant motions in the protein. All replicates for each system were combined 
before the analysis so that they all share the same subspace and could be directly 
compared. Each PCA trajectory contained one conformation per nanosecond per 
replicate (totaling 5001 and 2251 frames for the equilibrium and nonequilibrium 
simulations, respectively). The two principal components (PC1 and PC2) were used to 
assess the equilibration/relaxation of the simulations, and all systems were considered 
equilibrated after 50 ns. The Kubo-Onsager approach30-32 (see above) was used to 
analyse the nonequilibrium simulations and determine the response of the system to the 
annihilation of nicotine.  
 
Conformational stability of the α7 nAChR 
The structural stability of the receptor in the APO and NCT systems was examined by 
monitoring two system properties, namely the Cα root mean square deviation (RMSD) 
from the starting structure and the secondary structure content. As can be seen in Figure 
S6, both systems remain stable over the 500 ns simulations, and the average Cα RMSD 
profiles show a plateau after 50 ns. The average RMSD profiles slowly increased during 
the first tens of nanoseconds of simulation, reaching global values of around 0.37 nm 
for both systems. The stability of the systems is further demonstrated by the analysis of 
the secondary structure content of the receptor (using DSSP38) with only a small 
secondary structure loss (< 2%). 
Principal component analysis (PCA) was used to check the relaxation and sampling of 
the replicates.35-37 This analysis clearly shows (see Figure S6C) that the different 
replicates sample different regions of conformational space, improving the overall 






Figure S6. Equilibration and stability of the APO and NCT systems. A. Temporal evolution of the 
average Cα RMSD for the APO (red) and NCT (blue) systems. The Cα RMSD was calculated relative to 
the starting structures, and the averages were obtained over all replicates. B. Number of residues with 
secondary structure for the APO (red) and NCT (blue) systems. The DSSP software38 was used for the 
assignment of the secondary structure. C. PCA analysis of all replicates for the APO and NCT systems. 
All 10 replicates for each system were combined before the analysis and each PCA trajectory contained 
one conformation per nanosecond per replicate (totaling 5001 frames) with all the Cα atoms of the 
protein. The black dot corresponds to the structure used as the starting point for all the replicates. For a 




Dynamic behaviour of the nicotine ligands 
The dynamic behaviour of nicotine was monitored over the 10 µs of simulation time 
and, despite some fluctuations, both nicotine molecules maintained their positions 
throughout (Figure S7). Nevertheless, and despite the mobility of the ligands, the 
canonical interaction between the positively charged nitrogen atom of nicotine and 
TrpB (W171 from the principal subunits)39-41 is mostly present in both binding pockets 
(see Figures S8). This interaction has been shown experimentally to provide an anchor 
point for the agonist in the binding site.39 
The analysis of the dihedral angle between the pyridine and pyrrolidine rings of nicotine 
showed two possible binding modes (Figure S9): a preferred one (around 115⁰ ) 





Figure S7. Time evolution of the position of nicotine (NCT) during the equilibrium MD simulations. 
A, C. RMSD of the protonated secondary amine N of the nicotine molecules located in the first binding 
(A) and second (C) binding pocket. The RMSD was calculated relative to nicotine’s initial position. The 
averages represented (black line) were obtained over all 10 replicates. B, D. Superposition of the 
positions adopted by the protonated secondary amine N atom of nicotine in the first (B) and second (D) 
binding pockets during the MD simulations. In this image, each small blue dot represents the position of 
nicotine’s protonated secondary amine N atom. The structure used as the starting point for the simulations 




Figure S8. TrpB-nicotine distance over the simulation time. Distance between the side chain of 
TrpB (W171 in the principal subunits) and the charged secondary amine N atom of nicotine for the first 
(A) and second (B) binding pockets. C. Distance distributions for the two binding pockets (red line 







Figure S9- Dihedral (between the pyridine and pyrrolidine rings) angle distribution for nicotine in 
equilibrium MD simulations. This histogram reflects the dihedral distribution for nicotine in the two 
binding pockets. Similar distribution profiles are observed for the individual binding pockets, with the 




Nicotine-induced conformational changes 
The Cα positional deviations between the APO and the NCT systems were calculated as 
a function of the residue number for the last 10 ns of simulation in order to identify 
nicotine-induced conformational changes (Figures S10-S11). The final deviation values 
correspond to the average obtained over all 10 APO × 10 NCT pairs of trajectories. The 
Cα positional deviations were, then, mapped onto the average APO structure in order to 
identify the tridimensional location of the residues undergoing the largest 
rearrangements (Figures S12-S14). 
 
Figure S10. Average Cα positional deviation between the APO and the NCT systems for the two 
subunits forming the first binding pocket. The average deviation was determined from all 100 
combinations (resulting from the 10 APO × 10 NCT pairs of trajectories) of Cα RMSD between the 
average structures of the two systems. The vertical lines represent the standard deviation of the mean. The 
positions of some essential structural motifs are highlighted in light yellow. Note that despite some 
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differences in amplitude, similar structural rearrangements are observed in the two binding pockets with 
largest differences not only in loops B and C and in the extracellular selectivity filter (the region after 
loop A and the region before the loop E) but also at the interface between the ECD and the TMDs, 
namely in the Cys and F loops and in the M2-M3 linker.   
 
 
Figure S11. Average Cα positional deviation between the APO and the NCT systems for the two 
subunits that form the second binding pocket. For details, see Figure S9. Note that despite some 
differences in amplitude, similar structural rearrangements are observed in the two binding pockets with 
largest differences not only in loops B and C and in the extracellular selectivity filter (the region after 
loop A and the region before the loop E) but also at the interface between the ECD and the TMDs, 






Figure S12. Nicotine-induced conformational changes in the first binding pocket.  A. Comparison 
between the NCT and the APO systems for the first binding pocket. B. Detailed view of the binding 
pocket. C. Detailed view of the ECD-TMD interface. The structure colours and the cartoon thickness in 
this image are related to the average Cα positional deviation: the red regions correspond to the residues 





Figure S13. Nicotine-induced conformational changes at the second binding pocket.  A. Comparison 
between the NCT and the APO systems for the second binding pocket. B. Detailed view of the binding 






Figure S14. Zoom view of the nicotine-induced conformational changes in the extracellular 
vestibule in the first (top right image) and second (bottom right image). For details, see Figure S12. 
Note that the residues located next to loop A and E (right-side images) are located in the second layer of 
residues surrounding the binding pockets and are part of the extracellular selectivity filter. Mutations in 








Figure S15. Statistical correlations for loop F in the first binding pocket. On the left side of the 
image, the correlations between the Cα atom of G189 (located in the top part of loop F) in the 
complementary subunits and all the remaining Cα atoms are shown. On the right side, the correlations 
between the Cα atom of E195 (located in the lower part of loop F) and all the remaining Cα atoms are 
mapped.  In this image, the atoms that systematically move along the opposite/same direction as G189 (in 
the left side) or E195 (in the right side) have a correlation value of -1/1, whereas those whose movements 
are uncorrelated present value of 0. In this image, the correlations are mapped on the average NCT 












Figure S17. Statistical correlations for the M2-M3 linker. The correlations between the Cα atom of 
V290 (located in the M2-M3 linker) in the principal subunits and all the remaining Cα atoms are shown. 
In this image, the atoms that systematically move along the opposite/same direction as V290 have a 
correlation value of -1/1, respectively. In this image, the correlations are mapped on the average NCT 










Figure S18. Average Cα-positional deviation for the principal subunits in the 5 ns after the removal 
of nicotine from the binding pockets. The average deviation was calculated using the Kubo-Onsager 
approach30-32 for the comparison of the 450 short APO simulations with the NCT simulations. The 
positions of the structural motifs that form the binding pockets are highlighted in grey. The deviation 
obtained from the long simulations (500 ns) is also shown (dotted black line) for comparison, and it 
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corresponds to the average Cα positional deviation plotted in Figure S10 and S11. Note that the 
deviations observed after 5 ns are far from the scale of the rearrangements observed in the long 
equilibrium simulations, especially regarding the A, B and Cys loops. Note also the equivalent 
response of the two binding pockets to nicotine annihilation, with a similar order of events associated 









Figure S19. Average Cα-positional deviation for the complementary subunits in the 5 ns after 
nicotine´s removal from the binding pockets. The average deviation was calculated using the Kubo-
Onsager approach30-32 for the comparison of the 450 short APO simulations with the NCT simulations. 
The positions of the structural motifs that form the binding pockets are highlighted in grey. The deviation 
obtained from the long simulations (500 ns) is also shown (dotted black line) for comparison, and it 
corresponds to the average Cα positional deviation plotted in Figure S10 and S11. Note also the 
equivalent response of the two binding pockets to nicotine annihilation with a similar order of events 




Figure S20. Mapping of the average Cα-positional deviation in the 5 ns following nicotine removal 
from the first binding pocket. The Cα deviation between the short APO and the NCT simulations at 
specific times (0, 0.05, 0.5, 1, 3 and 5 ns) after removal of the ligand were calculated as a function of the 
residue number. The final deviation values correspond to the average obtained over all 450 pairs of 
simulations (see Figure S18-S19). In this image, the average deviations are mapped on the average APO 




Figure S21. Mapping of the average Cα-positional deviation in the 5 ns following the removal of 





Figure S22. Concerted motions in the binding pocket region and at the ECD:TMD interface in the 
equilibrium APO (A) and nonequilibrium (B) simulations. For the PCA of the equilibrium 
simulations, all 10 replicates were combined whereas for the nonequilibrium simulations, all 450 
replicates were combined before the analysis. Each PCA trajectory contains one conformation per 
nanosecond per replicate using the Cα atoms of the protein (except for the N- and C-terminal, and the loop 
between TMD M3 and M4). Note that in the equilibrium simulations (panel A), the individual motions 
associated with the signal propagation are also sampled (e.g. note the correlated motions between loop C 
and the top region of loop F or between the lower region of loop F and the M2-M3 linker in the principal 
components 2 and 8, respectively). On the nonequilibrium simulations, a concerted motion connecting the 
binding pocket (through loops C and F) and the TMDs (via the M2-M3 linker) can be observed (see 
principal components 3 and 7 in the panel B). It is also noteworthy that the PCA of the nonequilibrium 
simulations shows the same collective motions of the C-loop, the F loop and the M2-M3 linker as 
revealed by the Kubo-Onsager analysis. Nonetheless, the PCA analysis loses the temporal order of events 







Movie 1. Signal propagation in the human α7 nAChR (movie1.avi). This movie depicts signal 
propagation along the 5 ns after the deletion of nicotine from the first binding pocket in the human α7 







Movie 2- Signal propagation in the human α7 and α4β2 nAChR subtypes (movie2.avi). Note that 
despite the differences in propagation rates, the structural motifs involved, as well as the sequence of 





Movie 3. Concerted motion (principal component 3) between the binding pocket and the TMDs 
observed in the nonequilibrium simulations of the human α7 nAChR (movie3.avi). For details 
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